{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:43:15Z","timestamp":1791690195297,"version":"4.3.4"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,14]],"date-time":"2015-02-14T00:00:00Z","timestamp":1423872000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-0796-0","type":"journal-article","created":{"date-parts":[[2015,2,13]],"date-time":"2015-02-13T08:23:40Z","timestamp":1423815820000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON\u00ae-TB Gold In-tube"],"prefix":"10.1186","volume":"15","author":[{"given":"Chlo\u00e9","family":"Wyndham-Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violette","family":"Dirix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinda","family":"Schepers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Goffard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Domont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Libin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Loyens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Locht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Van Vooren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Mascart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,14]]},"reference":[{"key":"796_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.00042-10","volume":"24","author":"CK Kwan","year":"2011","unstructured":"Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev. 2011;24:351\u201376.","journal-title":"Clin Microbiol Rev"},{"key":"796_CR2","unstructured":"WHO | TB\/HIV facts 2012\u20132013 [http:\/\/www.who.int\/hiv\/topics\/tb\/tbhiv_facts_2013\/en\/index.html]"},{"key":"796_CR3","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1056\/NEJMsa031667","volume":"350","author":"CR Horsburgh Jr","year":"2004","unstructured":"Horsburgh Jr CR. Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med. 2004;350:2060\u20137.","journal-title":"N Engl J Med"},{"key":"796_CR4","unstructured":"WHO global tuberculosis control report 2012 [http:\/\/apps.who.int\/iris\/bitstream\/10665\/91355\/1\/9789241564656_eng.pdf]"},{"key":"796_CR5","first-page":"1","volume":"59","author":"GH Mazurek","year":"2010","unstructured":"Mazurek GH, Jereb J, Vernon A, LoBue P, Goldberg S, Castro K. IGRA expert committee, centers for disease control and prevention (CDC): updated guidelines for using interferon gamma release assays to detect mycobacterium tuberculosis infection - united states, 2010. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control. 2010;59:1\u201325.","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control"},{"key":"796_CR6","unstructured":"ECDC 2011: use of interferon-gamma release assays in support of TB diagnosis. [http:\/\/www.ecdc.europa.eu\/en\/publications\/Publications\/1103_GUI_IGRA.pdf]"},{"key":"796_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.7326\/0003-4819-119-3-199308010-00002","volume":"119","author":"N Markowitz","year":"1993","unstructured":"Markowitz N, Hansen NI, Wilcosky TC, Hopewell PC, Glassroth J, Kvale PA, et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Pulmonary Complications of HIV Infection Study Group. Ann Intern Med. 1993;119:185\u201393.","journal-title":"Ann Intern Med"},{"key":"796_CR8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1093\/clinids\/17.6.968","volume":"17","author":"RE Huebner","year":"1993","unstructured":"Huebner RE, Schein MF, Bass Jr JB. The tuberculin skin test. Clin Infect Dis Off Publ Infect Dis Soc Am. 1993;17:968\u201375.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"796_CR9","doi-asserted-by":"publisher","first-page":"e32482","DOI":"10.1371\/journal.pone.0032482","volume":"7","author":"M Santin","year":"2012","unstructured":"Santin M, Mu\u00f1oz L, Rigau D. Interferon-\u03b3 release assays for the diagnosis of tuberculosis and tuberculosis infection in HIV-infected adults: a systematic review and meta-analysis. PLoS One. 2012;7:e32482.","journal-title":"PLoS One"},{"key":"796_CR10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/QAI.0b013e31820b07ab","volume":"56","author":"A Cattamanchi","year":"1999","unstructured":"Cattamanchi A, Smith R, Steingart KR, Metcalfe JZ, Date A, Coleman C, et al. Interferon-gamma release assays for the diagnosis of latent tuberculosis infection in HIV-infected individuals: a systematic review and meta-analysis. J Acquir Immune Defic Syndr. 1999;56:230\u20138.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"796_CR11","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1164\/rccm.201209-1621CI","volume":"188","author":"G Redelman-Sidi","year":"2013","unstructured":"Redelman-Sidi G, Sepkowitz KA. Interferon gamma release assays in the diagnosis of latent tuberculosis infection among immunocompromised adults. Am J Respir Crit Care Med. 2013;188:422\u201331.","journal-title":"Am J Respir Crit Care Med"},{"key":"796_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.tube.2006.01.016","volume":"86","author":"C Locht","year":"2006","unstructured":"Locht C, Hougardy J-M, Rouanet C, Place S, Mascart F. Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis. Tuberc Edinb Scotl. 2006;86:303\u20139.","journal-title":"Tuberc Edinb Scotl"},{"key":"796_CR13","doi-asserted-by":"publisher","first-page":"e926","DOI":"10.1371\/journal.pone.0000926","volume":"2","author":"J-M Hougardy","year":"2007","unstructured":"Hougardy J-M, Schepers K, Place S, Drowart A, Lechevin V, Verscheure V, et al. Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis. PLoS One. 2007;2:e926.","journal-title":"PLoS One"},{"key":"796_CR14","doi-asserted-by":"publisher","first-page":"e71088","DOI":"10.1371\/journal.pone.0071088","volume":"8","author":"R Dessein","year":"2013","unstructured":"Dessein R, Corbi\u00e8re V, Nortier J, Dratwa M, Gastaldello K, Pozdzik A, et al. Heparin-binding haemagglutinin, a New tool for the detection of latent mycobacterium tuberculosis infection in hemodialysis patients. PLoS One. 2013;8:e71088.","journal-title":"PLoS One"},{"key":"796_CR15","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1128\/CVI.00047-12","volume":"19","author":"AG Loxton","year":"2012","unstructured":"Loxton AG, Black GF, Stanley K, Walzl G. Heparin-binding hemagglutinin induces IFN-\u03b3\u2009+\u2009IL-2+ IL-17+ multifunctional CD4+ T cells during latent but Not active tuberculosis disease. Clin Vaccine Immunol CVI. 2012;19:746\u201351.","journal-title":"Clin Vaccine Immunol CVI"},{"key":"796_CR16","unstructured":"Registre belge de la tuberculose 2012 [http:\/\/www.fares.be\/documents\/Regtbc2012.pdf]."},{"key":"796_CR17","unstructured":"TB-IRIS Case Definition - MED - International Network Study of HIV-Associated IRIS, University of Minnesota [http:\/\/www.inshi.umn.edu\/definitions\/TB_IRIS\/home.html]"},{"key":"796_CR18","unstructured":"Recommandations concernant le d\u00e9pistage cibl\u00e9 et le traitement de l\u2019infection tuberculeuse latente [http:\/\/www.fares.be\/documents\/recomm.pdf]"},{"key":"796_CR19","doi-asserted-by":"publisher","first-page":"e8517","DOI":"10.1371\/journal.pone.0008517","volume":"4","author":"RN Van Zyl-Smit","year":"2009","unstructured":"Van Zyl-Smit RN, Zwerling A, Dheda K, Pai M. Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PLoS One. 2009;4:e8517.","journal-title":"PLoS One"},{"key":"796_CR20","doi-asserted-by":"crossref","unstructured":"Wyndham-Thomas C, Corbi\u00e8re V, Dirix V, Smits K, Domont F, Libin M, et al.: A short incubation Heparin-Binding Haemagglutinin interferon-gamma release assay for the detection of latent tuberculosis: the key role of effector memory CD4+ T lymphocytes. Clin Vaccine Immunol CVI 2014.","DOI":"10.1128\/CVI.00651-13"},{"key":"796_CR21","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1086\/338833","volume":"185","author":"C Masungi","year":"2002","unstructured":"Masungi C, Temmerman S, Van Vooren J-P, Drowart A, Pethe K, Menozzi FD, et al. Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. J Infect Dis. 2002;185:513\u201320.","journal-title":"J Infect Dis"},{"key":"796_CR22","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1086\/430930","volume":"192","author":"ST Temmerman","year":"2005","unstructured":"Temmerman ST, Place S, Debrie A-S, Locht C, Mascart F. Effector functions of heparin-binding hemagglutinin-specific CD8+ T lymphocytes in latent human tuberculosis. J Infect Dis. 2005;192:226\u201332.","journal-title":"J Infect Dis"},{"key":"796_CR23","unstructured":"WHO | Tuberculosis country profiles [http:\/\/www.who.int\/tb\/country\/data\/profiles\/en\/]"},{"key":"796_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/0471249688","volume-title":"Categorical Data Analysis","author":"A Agresti","year":"2002","unstructured":"Agresti A. Categorical Data Analysis. 2nd ed. United States of America: John Wiley & Sons; 2002.","edition":"2"},{"issue":"Suppl 5","key":"796_CR25","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1097\/01.aids.0000391023.03037.1f","volume":"24","author":"H Getahun","year":"2010","unstructured":"Getahun H, Granich R, Sculier D, Gunneberg C, Blanc L, Nunn P, et al. Implementation of isoniazid preventive therapy for people living with HIV worldwide: barriers and solutions. AIDS Lond Engl. 2010;24 Suppl 5:S57\u201365.","journal-title":"AIDS Lond Engl"},{"issue":"Suppl 5","key":"796_CR26","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1097\/01.aids.0000391021.18284.12","volume":"24","author":"R Lester","year":"2010","unstructured":"Lester R, Hamilton R, Charalambous S, Dwadwa T, Chandler C, Churchyard GJ, et al. Barriers to implementation of isoniazid preventive therapy in HIV clinics: a qualitative study. AIDS Lond Engl. 2010;24 Suppl 5:S45\u20138.","journal-title":"AIDS Lond Engl"},{"key":"796_CR27","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1002\/eji.201142297","volume":"42","author":"SG Smith","year":"2010","unstructured":"Smith SG, Lecher S, Blitz R, Locht C, Dockrell HM. Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination. Eur J Immunol. 2010;42:2511\u201322.","journal-title":"Eur J Immunol"},{"key":"796_CR28","doi-asserted-by":"publisher","first-page":"e18315","DOI":"10.1371\/journal.pone.0018315","volume":"6","author":"G Delogu","year":"2011","unstructured":"Delogu G, Chiacchio T, Vanini V, Butera O, Cuzzi G, Bua A, et al. Methylated HBHA produced in M smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PloS One. 2011;6:e18315.","journal-title":"PloS One"},{"key":"796_CR29","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.tim.2009.02.005","volume":"17","author":"DB Young","year":"2009","unstructured":"Young DB, Gideon HP, Wilkinson RJ. Eliminating latent tuberculosis. Trends Microbiol. 2009;17:183\u20138.","journal-title":"Trends Microbiol"},{"key":"796_CR30","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1146\/annurev-immunol-032712-095939","volume":"31","author":"A O\u2019Garra","year":"2013","unstructured":"O\u2019Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MPR. The immune response in tuberculosis. Annu Rev Immunol. 2013;31:475\u2013527.","journal-title":"Annu Rev Immunol"},{"key":"796_CR31","doi-asserted-by":"publisher","first-page":"e43285","DOI":"10.1371\/journal.pone.0043285","volume":"7","author":"V Corbi\u00e8re","year":"2012","unstructured":"Corbi\u00e8re V, Pottier G, Bonkain F, Schepers K, Verscheure V, Lecher S, et al. Risk stratification of latent tuberculosis defined by combined interferon gamma release assays. PLoS One. 2012;7:e43285.","journal-title":"PLoS One"},{"key":"796_CR32","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1164\/rccm.201001-0083OC","volume":"182","author":"S Place","year":"2010","unstructured":"Place S, Verscheure V, de San N, Hougardy J-M, Schepers K, Dirix V, et al. Heparin-binding, hemagglutinin-specific IFN-gamma synthesis at the site of infection during active tuberculosis in humans. Am J Respir Crit Care Med. 2010;182:848\u201354.","journal-title":"Am J Respir Crit Care Med"},{"key":"796_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1164\/rccm.200701-084OC","volume":"176","author":"J-M Hougardy","year":"2007","unstructured":"Hougardy J-M, Place S, Hildebrand M, Drowart A, Debrie A-S, Locht C, et al. Regulatory T cells depress immune responses to protective antigens in active tuberculosis. Am J Respir Crit Care Med. 2007;176:409\u201316.","journal-title":"Am J Respir Crit Care Med"},{"key":"796_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1182\/blood-2012-07-409755","volume":"121","author":"MF Chevalier","year":"2013","unstructured":"Chevalier MF, Weiss L. The split personality of regulatory T cells in HIV infection. Blood. 2013;121:29\u201337.","journal-title":"Blood"},{"key":"796_CR35","doi-asserted-by":"publisher","first-page":"46079","DOI":"10.1074\/jbc.M204698200","volume":"277","author":"EY Choe","year":"2002","unstructured":"Choe EY, Schoenberger ES, Groopman JE, Park I-W. HIV Nef inhibits T cell migration. J Biol Chem. 2002;277:46079\u201384.","journal-title":"J Biol Chem"},{"key":"796_CR36","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1136\/thx.2011.160168","volume":"66","author":"T Oni","year":"2011","unstructured":"Oni T, Burke R, Tsekela R, Bangani N, Seldon R, Gideon HP, et al. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax. 2011;66:669\u201373.","journal-title":"Thorax"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-0796-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0796-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-0796-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T08:19:51Z","timestamp":1630570791000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-0796-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,14]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["796"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-0796-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,14]]},"assertion":[{"value":"9 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"59"}}